When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.

Two new small interfering RNA (siRNA) therapeutics (both Arrowhead Pharmaceuticals), each targeting different genes involved in the regulation of triglyceride-rich lipoproteins, have been shown to be ...

MADRID, Spain—Olezarsen (Ionis Pharmaceuticals), an antisense oligonucleotide that targets APOC3 messenger RNA (mRNA), successfully lowers triglyceride levels compared with placebo by 6 months among ...

The evidence for elevated triglycerides, as a cardiac risk factor, is nowhere near as well understood as the risk from high LDL and low HDL cholesterol. However, the growing body of epidemiologic ...